|
|
||||
![]() | ||||
|
|
|
Select from the search options to widen or narrow the search results.
Recurrent Ovarian Cancer (GOG 0213) Purpose of the study: The first purpose of the study is to determine if it is beneficial to the patient to have a second debulking surgery. The second purpose is to compare the standard of care chemotherapy of Carboplatin and Taxol to that of Chemotherapy with the addition of Bevacizumab. Participants must :
For more information at Aurora West Allis please contact, Carol Burrows at 414-328-6085 or carol.burrows@aurora.org Principal Investigator: Peter Johnson M.D. For more information at St Lukes please contact Carol Thomas at 414- or carol.thomas@aurora.org Principal Investigator: Scott Kamelle M.D. For more information at Slinger please contact Carol Thomas at414-649-5605 or carol.thomas@aurora.org Principal Investigator: Jonathan Triesman MD For more information at VLCC Sheboygan please contact Deborah Gray at 920-457-6800 deb.gray@aurora.org or Mary Theodoroff at 920-457-6800 mary.theodoroff@aurora.org Principal Investigator: Max Haid MD Clinical trial location(s)Aurora St. Luke's Medical Center2900 West Oklahoma Avenue Milwaukee, WI 53215 VLCC Sheboygan (AMG) VLCC - Slinger West Allis Memorial Hospital
[ previous page ]
|
||
|
|
|
|||